Regulation of P-glycoprotein 1 and 2 gene expression and protein activity in two MCF-7/Dox cell line subclones

British Journal of Cancer

Volumn 73, Issue 3, 1996, Pages 307-315

  Davies, R ^a   Budworth, J ^a   Riley, J ^a   Snowden, R ^a   Gescher, A ^a   Gant, T W ^a  

^a MRC TOXICOLOGY UNIT   (United Kingdom)

Author keywords

Flow cytometry; Gene expression; MCF 7; Multidrug resistance; Protein kinase C

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P;

ARTICLE; CANCER CHEMOTHERAPY; CELL SELECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030039548     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.54     Document Type: Article

References (46)

1. AHMAD S AND GLAZER RI. (1993). Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells. Mol. Pharmacol., 43, 858-862.
2. AHMAD S, SAFA AR AND GLAZER RI. (1994). Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system. Biochemistry, 33, 10313-10318.
3. BATES SE, LEE JS, DICKSTEIN B, SPOLYAR M AND FOJO AT. (1993). Differential modulation of P-glycoprotein transport by protein kinase C inhibition. Biochemistry, 32, 9156-9164.
4. BATIST G, TULPULE A, SINHA BK, KATKI AG, MYERS C AND COWAN KH. (1986). Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem., 261, 15544-15549.
5. BECK W, MUELLER TJ AND TANZER LR. (1979). Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukaemic lymphoblasts. Cancer Res., 39, 2070-2076.
6. BRADFORD MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem., 72, 248-254.
7. BROWN PC, THORGEIRSSON SS AND SILVERMAN JA. (1993). Cloning and regulation of the rat mdr2 gene. Nucleic. Acids Res., 21, 3885-3891.
8. CHAMBERS TC, McAVOY EM, JACOBS JW AND EILON G. (1990). Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J. Biol. Chem., 265, 7679-7686.
9. CHAMBERS TC, ZHENG B AND KUO JF. (1992). Regulation by phorbol ester and protein kinase C inhibitors and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Mol. Pharmacol., 41, 1008-1015.
10. CHAN HSL, BRADLEY G, THORNER P, HADDAD G, GALLIE BL AND LING V. (1988). A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug resistant human ovarian carcinoma cell lines. Methods Lab. Invest., 59, 870-875.
11. CHAUDHARY PM AND RONINSON IB. (1992). Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncology Research, 4, 281-290.
12. CHIN JE, SOFFIR R, NOONAN KE, CHOI K AND RONINSON IB. (1989). Structure and expression of the human MDR (P-glycoprotein) gene family. Mol. Cell. Biol., 9, 3808-3820.
13. CHOI K, FROMMEL THO, STERN RK, PEREZ CF, KRIEGLER M, TSURUO T AND RONINSON IB. (1991). Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection. Proc. Natl Acad. Sci. USA. 88, 7386-7390.
14. COWAN KH, BATIST G, TUPULE A, SINHA BK AND MYERS CE. (1986). Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc. Natl Acad. Sci. USA, 83, 9328-9332.
15. CURRIER SJ, KANE SE, WILLINGHAM MC, CARDARELLI CO, PASTAN I AND GOTTESMAN MM. (1992). Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters. J. Biol. Chem., 267, 25153-25159.
16. EFFERTH T AND OSIEKA R. (1993). Clinical relevance of the MDR-I gene and its gene product, P-glycoprotein, for cancer chemotherapy: A meta analysis. Tumor Diagnostik und Therapie, 14, 238-243.
17. ENDICOTT JA AND LING V. (1989). The biochemistry of P-glycoprotein mediated multidrug resistance. Ann. Rev. Biochem., 58, 137-171.
18. FAIRCHILD CR, KAO-SHAN CHIEN-S, WANG-PENG J, ROSEN N, ISRAEL MA, MALERA PW, COWAN KH AND GOLDSMITH ME. (1987). Isolation of amplified and overexpressed DNA sequences from adriamycin resistant human breast cancer cells. Cancer Res., 47, 5141-5148.
19. FINE RL, PATEL J AND CHABNER BA. (1988). Phorbol esters induce multidrug resistance in human breast cancer cells. Proc. Natl Acad. Sci. USA, 85, 582-586.
20. FORT P, MARTY L, PIECHAEZYL M, SABROUTY SE, DANI C, JEANTEUR P AND BLANCHARD JM. (1985). Various rat tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res., 13, 1431-1443.
21. FUTSCHER BW, BLAKE LL, GERLACH JH, GROGAN TIM AND DALTON WS. (1993). Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens. Anal. Biochem., 213, 414-421.
22. GANT TW, SILVERMAN JA, BISGAARD HC, BURT RK, MARINO PA AND THORGEIRSSON SS. (1991). Regulation of 2-acetylamino-fluorene-and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcinog., 4, 499-509.
23. GANT TW, SILVERMAN JA AND THORGEIRSSON SS. (1992). Regulation of P-glycoprotein expression in hepatocyte cultures and liver cell lines by a trans-acting transcriptional repressor. Nucleic Acids Res., 20, 2841-2846.
24. GREIF H, BEN-CHAIM J, SHIMON T, BECHOR E, ELDAR H AND LIVNEH E. (1992). The protein kinase C related PKC-L (Eta) gene product is localized to cell nucleus. Mol. Cell. Biol., 12, 1304-1311.
25. KARTNER N, RIORDAN JR AND LING V. (1983a). Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, 221, 1285-1288.
26. KARTNER N, SHALES M, RIORDAN JR AND LING V. (1983b). Daunorubicin-resistant chinese hamster ovary cells expressing multidrug resistance and cell surface P-glycoprotein. Cancer Res., 43, 44143-4419.
27. KOHNO K, TANIMURA H, SATO S, NAKAYAMA Y, MAKINO Y, WADA M, FOJO AT AND KUWANO M. (1994). Cellular control of human multidrug resistance 1 (mdr-1) gene expression in absence and presence of gene amplification in human cancer cells. J. Biol. Chem., 269, 20503-20508.
28. LEE CH, BRADLEY G, ZHANG JT AND LING V. (1993). Differential expression of P-glycoprotein genes in primary rat hepatocyte culture. J. Cell. Physiol., 157, 392-402.
29. LUDESCHER C, HILBE W, EISTERER W, PREUSS E, HUBER C, GOTWALD M, HOFMANN J AND THALER J. (1993). Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay. J. Natl Cancer Inst., 85, 1751-1758.
30. MA L, MARQUARDT D, TAKEMOTO L AND CENTER MS. (1991). Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J. Biol. Chem., 266, 5593-5599.
31. MADDEN MJ, MORROW CS, NAKAGAWA M, GOLDSMITH ME, FAIRCHILD CR AND COWAN KH. (1993). Identification of 5′ and 3′ sequences involved in the regulation of transcription of the human mdr1 gene in vivo. J. Biol. Chem., 268, 8290-8297.
32. MOLINARI A, CIANFRIGLIA M, MESCHINI S, CALCABRINI A AND ARANCIA G. (1994). P-glycoprotein expression in the Golgi apparatus of multidrug-resistant cells. Int. J. Cancer, 59, 789-795.
33. MORROW CS, CHIU J AND COWAN KH. (1992). Posttranscriptional control of glutathione S-transferase π gene expression in human breast cancer cells. J. Biol. Chem., 267, 10544-10550.
34. NG WF, SARANGI F, ZASTAWNY RL, VEINOT-DREBOT L AND LING V. (1989). Identification of members of the P-glycoprotein multigene family. Mol. Cell. Biol., 9, 1224-1232.
35. RIORDAN JR AND LING V. (1979). Purification of P-Glycoprotein from plasma membrane vesicles of chinese hamster ovary cell mutants with reduced colchicine permeability. J. Biol. Chem., 254, 12701-12705.
36. SAMBROOK J, FRITSCH EF AND MANIATIS T. (1989). Molecular Cloning, 2nd edn, Vol. 1-3. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
37. SCHINKEL AH, ROELOFS MEM AND BORST P. (1991). Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific antibodies. Cancer Res., 51, 2628-2635.
38. SCHINKEL AH, ARCECI RJ, SMIT JJM, WAGENAAR E, BAAS F, DOLLE M, TSURUO T, MECHETNER EB, RONINSON IB AND BORST P. (1993). Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein. Int. J. Cancer, 55, 478-484.
39. SHEN D, CARDARELLI C, HWANG J, CORNWELL MM, RICHERT N, ISHI S, PASTAN I AND GOTTESMAN MM. (1986a). Multiple drug resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin or vinblastine show changes in expression of specific proteins. J. Biol. Chem., 261, 7762-7770.
40. SHEN D-W, FOJO A, CHIN JE, RONINSON IB, RICHERT N, PASTAN I AND GOTTESMAN MM. (1986b). Human multidrug-resistant cell lines: Increased mdr1 expression can precede gene amplification. Science, 232, 643-645.
41. SLAPAK CA, KHARBANDA S, SALEEM A AND KUFE DW. (1993). Defective translocation of protein kinase C in multidrug-resistant HL-60 cells confers a reversible loss of phorbol ester-induced monocytic differentiation. J. Biol. Chem., 268, 12267-12273.
42. STANWELL C, GESCHER A, BRADSHAW TD AND PETTIT GR. (1994). The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells. Int. J. Cancer, 56, 585-592.
43. UEDA K, CARDARELLI C, GOTTESMAN MM AND PASTAN I. (1987). Expression of a full length cDNA for the human 'MDR1' gene confers resistance to colchicine, doxorubicin and vinblastine. Proc. Natl Acad. Sci. USA, 84, 3004-3008.
44. VAN DER BLIEK AM AND BORST P. (1989). Multidrug Resistance, Adv. Cancer Res., 52, 165-203.
45. YU G, AHMAD S, AQUINO A, FAIRCHILD CR, TREPEL JB, OHNO S, SUZUKI K, TSURO T, COWAN KH AND GLAZER RI. (1991). Transfection with protein kinase Cα confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Communications, 3, 181-189.
46. ZHANG F, RILEY J AND GANT TN. (1996). Use of internally controlled reverse transcriptase-polymerase chain reaction for absolute quantitation of individual multidrug resistance gene transcripts in tissue samples. Electrophoresis, 17, (in press).